Tirzepatide, the recently approved medication, is sparking considerable buzz within the scientific community. It functions differently from existing diabetes medications, targeting multiple receptors involved in glucose regulation and appetite . Initial trials have demonstrated impressive efficacy in controlling blood sugar in individuals with type